Drug Shortage Report for APO-DIVALPROEX

Last updated on 2017-07-26 History
Report ID 12805
Drug Identification Number 02239699
Brand name APO-DIVALPROEX
Common or Proper name DIVALPROEX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VALPROIC ACID
Strength(s) 250MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100 BTL
ATC code N03AG
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-06-23
Actual start date 2017-06-19
Estimated end date 2017-07-31
Actual end date 2017-07-25
Shortage status Resolved
Updated date 2017-07-26
Company comments APO-DIVALPROEX 250 MG ECT 500 BTL is available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-07-26 French Compare
v8 2017-07-26 English Compare
v7 2017-07-11 French Compare
v6 2017-07-11 English Compare
v5 2017-06-20 English Compare
v4 2017-06-19 French Compare
v3 2017-06-19 English Compare
v2 2017-06-15 French Compare
v1 2017-06-15 English Compare

Showing 1 to 9 of 9